Germany develops new lung disease monitoring technology

Release date: 2009-08-19




On August 12, the Heidelberg University School of Medicine released a statement announcing a groundbreaking development in lung disease monitoring. Researchers have created a new technology capable of more accurately tracking conditions such as emphysema and chronic bronchitis. The method has already shown promising results in experiments conducted on mice and is expected to be adapted for human use in the future.

According to the findings, lung macrophages release excessive amounts of matrix metalloproteinase-12 (MMP-12) when exposed to long-term smoking or other environmental stressors. This overproduction leads to damage in the alveolar structure, ultimately contributing to the development of emphysema. To address this, scientists at Heidelberg developed a fluorescent probe that uses fluorescence resonance energy transfer (FRET) to detect MMP-12 activity, providing insight into whether the lungs are undergoing pathological changes.

In their experiments, the researchers tested this probe on rats with lung inflammation and observed a significant increase in MMP-12 enzyme activity on the surface of lung macrophages. This discovery opens up new possibilities for early detection and monitoring of lung diseases.

The team now aims to refine the technique so it can be easily implemented in standard clinical settings, potentially complementing traditional diagnostic tools like chest X-rays. They also hope to expand the application of this technology to monitor other enzymes involved in lung inflammation, which could lead to a better understanding of the underlying mechanisms of various respiratory conditions.

This innovative research was recently published in the latest issue of the prestigious British journal Nature and Chemical Biology. The study marks an important step forward in the field of pulmonary diagnostics and offers new hope for patients suffering from chronic lung diseases.

Antiviral & Anti-cancer

Antiviral:

Antiviral drugs are a class of medication used specifically for treating viral infections. Like antibiotics and broad-spectrum antibiotics for bacteria, most antivirals are used for specific viral infections, while a broad-spectrum antiviral is effective against a wide range of viruses. Unlike most antibiotics, antiviral drugs do not destroy their target pathogen; instead they inhibit their development.


Antiviral drugs are one class of antimicrobials, a larger group which also includes antibiotic (also termed antibacterial), antifungal and antiparasitic drugs, or antiviral drugs based on monoclonal antibodies. Most antivirals are considered relatively harmless to the host, and therefore can be used to treat infections. They should be distinguished from viricides, which are not medication but deactivate or destroy virus particles, either inside or outside the body. Antivirals also can be found in essential oils of some herbs, such as eucalyptus oil and its constituents.Related Products:antiviral drugs,anti-cancer drugs.


Anti-cancer:

Anticancer, or Antineoplastic, drugs are used to treat malignancies, or cancerous growths. Drug therapy may be used alone, or in combination with other treatments such as surgery or radiation therapy.

For the treatment :

Anal cancer

Bladder cancer

Bone cancer

Breast cancer

Cervical cancer

Colon cancer

Colorectal cancer

Endometrial cancer

Kidney cancer

Leukemia

Liver cancer

Lymphoma

Ovarian cancer

Pancreatic cancer

Prostate cancer

Stomach cancer

Testicular cancer

Thyroid cancer

Vaginal cancer

Vulvar cancer

Antiviral & Anti-cancer,Acyclovir Tablet,Ondansetron Injection,Anti-Cancer Drug,Asparaginase Drug

NOUVASANT GROUP LTD. , https://www.nouvasant.com